Omarigliptin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The dipeptidyl peptidase-4 (DPP-4) inhibitors are novel oral hypoglycemic drugs which have been in clinical use for the past 10…
The invention discloses Omarigliptin and a preparation method of an intermediate of the Omarigliptin, and provides a preparation…
Zvysujici se prevalence diabetes mellitus 2. typu je zavažným epidemiologickým, klinickým a ekonomickým problemem. Kvalitni…
The invention relates to novel omarigliptin salt and crystal form products of the omarigliptin salt, and belongs to the technical…
The invention provides a synthetic method for a formula (I) compound omarigliptin. A formula (2) compound and a formula (3…
Der einmal wöchentlich einzunehmende DPP-4-Hemmer Omarigliptin senkt das HbA1c genauso gut wie Sitagliptin 100 mg/d und ist…
Das Unternehmen MSD hat erstmals einen DPP-4-Hemmer auf der Zielgeraden, der den Blutzucker mit einer Tablette pro Woche genauso…